Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Pigment Epithelium-Derived Factor Expression in the Neovascular Iris in Retinal Diseases

Table 2

Summary of clinical findings (mean ± standard deviation).

Group	Total	POAG	NVG secondary to PDR	NVG secondary to CRVO	value
Age	50.88 ± 10.76	54.38 ± 8.50	50.13 ± 8.97	48.13 ± 12.80	0.378
Gender (male/female)	23/16	6/6	8/4	9/6	0.641
BCVA (logMAR)	2.15 ± 1.18	1.27 ± 0.92	2.59 ± 1.33	2.59 ± 0.79	0.018
IOP at the time of surgery (mmHg)	37.04 ± 13.25	33.38 ± 14.54	38.63 ± 14.67	39.13 ± 11.24	0.358

We included 39 eyes from 39 patients (12 eyes from 12 patients with POAG, 12 eyes from 12 patients with NVG secondary to PDR, and 15 eyes from 15 patients with NVG secondary to CRVO). One-way ANOVA; χ² test. NVG: neovascular glaucoma; POAG: primary open-angle glaucoma; PDR: proliferative diabetic retinopathy; CRVO: central retinal vein occlusion; BCVA: best-corrected visual acuity; IOP: intraocular pressure.